These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2144544)

  • 1. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
    Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
    J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B- and T-cell activation in the thymus of patients with myasthenia gravis.
    Cohen-Kaminsky S; Leprince C; Galanaud P; Richards Y; Berrih-Aknin S
    Thymus; 1989; 14(1-3):187-93. PubMed ID: 2623739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
    Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel CD2+ human thymic B cell subset.
    Punnonen J; de Vries JE
    J Immunol; 1993 Jul; 151(1):100-10. PubMed ID: 7686927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.
    Okumura M; Ohta M; Takeuchi Y; Shiono H; Inoue M; Fukuhara K; Kadota Y; Miyoshi S; Fujii Y; Matsuda H
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1922-8. PubMed ID: 14688707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered intrathymic T-cell repertoire in human myasthenia gravis.
    Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
    Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
    Willcox HN; Newsom-Davis J; Calder LR
    Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of T- and B-lymphocyte activation in severely burned patients.
    Schlüter B; König W; Köller M; Erbs G; Müller FE
    J Trauma; 1991 Feb; 31(2):239-46. PubMed ID: 1825229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis.
    Durelli L; Massazza U; Poccardi G; Ferrio MF; Cavallo R; Maggi G; Casadio C; Di Summa M; Bergamini L
    Ann Neurol; 1990 Feb; 27(2):174-80. PubMed ID: 2317013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis.
    Shinomiya N; Yata J
    Clin Exp Immunol; 1981 Nov; 46(2):277-85. PubMed ID: 6978218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
    Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
    J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects.
    Willcox N; Schluep M; Sommer N; Campana D; Janossy G; Brown AN; Newsom-Davis J
    Q J Med; 1989 Nov; 73(271):1071-87. PubMed ID: 2623139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.
    Newsom-Davis J; Willcox N; Calder L
    N Engl J Med; 1981 Nov; 305(22):1313-8. PubMed ID: 7290153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.
    Willcox HN; Newsom-Davis J; Calder LR
    Clin Exp Immunol; 1983 Nov; 54(2):378-86. PubMed ID: 6317238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte subpopulations in non-neoplastic thymus from myasthenia gravis patients.
    Piantelli M; Musiani P; Lauriola L; Carbone A; Tonali P; Dina MA
    Clin Exp Immunol; 1980 Jul; 41(1):19-24. PubMed ID: 6969152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.